Clinical Trials Browser

Observational × Has results × Chemotherapy-Induced Febrile Neutropenia × Clear all

NCT02178475 2018-07-23

Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy

943 enrolled 28 charts

BreastClassical hematology

Breast Neoplasms, Chemotherapy-Induced Febrile Neutropenia